Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin f…

Drug Manufacturers - General

US, New York [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Major Shareholders · Proxy Ben. Owners

Shareholders

Major Shareholders · Structure

Breakdown

The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Pfizer Inc.

Institutional

Insider

Retail

67.48%

0.05%

32.47%

Intraday

Shares Outstanding

5,666,990,000

Volume

27,472,450

Volume on Avg.

43,391,963

Beneficial Owners Beta

Beneficial owners who control a significant portion of the shares outstanding.

SEC Source

Form 3/4/5

Owner	Shares	Equivalence - $26.30 per share	Last Form/Filing	Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
Echevarria Joseph Internal : Director	0	$0	04/26/24	0 x $0 = $0
Blaylock Ronald E Internal : Director	0	$0	04/26/24	0 x $0 = $0
Buckley Mortimer J Internal : Director	0	$0	10/15/24	0 x $0 = $0
Quincey James Internal : Chairman and CEO	0	$0	04/26/24	0 x $0 = $0
Smith James C Internal : Director	0	$0	01/03/25	0 x $0 = $0
Taraporevala Cyrus Internal : Director	0	$0	07/01/24	0 x $0 = $0
Johnson Rady A Internal : Executive Vice President	0	$0	07/16/24	0 x $0 = $0
Narayen Shantanu Internal : Director	0	$0	04/26/24	0 x $0 = $0
Bourla Albert Internal : Chairman & CEO	0	$0	08/16/24	0 x $0 = $0
Gottlieb Scott Internal : Director	100,000,000	$2,630,000,000.00	10/31/24	P 10,000,000 x $28.24 = $282,400,000.00
Fonseca Lidia Internal : Executive Vice President	0	$0	09/16/24	0 x $0 = $0
Denton David M Internal : Chief Financial Officer & EVP	379,190,000	$9,972,697,000.00	06/03/24	F 121,070,000 x $28.66 = $3,469,866,200.00
Mcdermott Michael Internal : Executive Vice President	754,630,000	$19,846,769,000.00	02/27/24	F 60,630,000 x $27.18 = $1,647,923,400.00
Dolsten Mikael Internal : President R&D	3,431,660,000	$90,252,658,000.00	02/27/24	F 248,220,000 x $27.76 = $6,890,587,200.00
Susman Sally Internal : Executive Vice President	2,181,480,000	$57,372,924,000.00	02/27/24	M 638,370,000 x $27.34 = $17,453,035,800.00
Malik Aamir Internal : Executive Vice President	0	$0	02/28/24	0 x $0 = $0
Sahni Payal Internal : Executive Vice President	0	$0	09/16/24	0 x $0 = $0
Lankler Douglas M Internal : Executive Vice President	2,309,200,000	$60,731,960,000.00	02/27/24	M 957,550,000 x $27.34 = $26,179,417,000.00
Damico Jennifer B. Internal : SVP & Controller	0	$0	05/16/24	0 x $0 = $0
Baum Andrew Internal : Executive Vice President	0	$0	08/02/24	0 x $0 = $0
Nora Johnson Suzanne M Internal : Director	0	$0	04/26/24	0 x $0 = $0
Littman Dan R. Internal : Director	0	$0	04/26/24	0 x $0 = $0
Hockfield Susan Internal : Director	0	$0	04/26/24	0 x $0 = $0
Hobbs Helen Internal : Director	0	$0	04/26/24	0 x $0 = $0
Desmond-Hellmann Susan Internal : Director	0	$0	04/26/24	0 x $0 = $0
Boshoff Christoffel Internal : Executive Vice President	1,548,440,000	$40,723,972,000.00	02/27/24	A 154,550,000 x $0 = $0
De Germay Alexandre Internal : Executive Vice President	743,770,000	$19,561,151,000.00	02/28/24	A 743,770,000 x $0 = $0